What are Scope 3 emissions and why are they crucial for Zuellig Pharma?

Question

Accepted Answer

Scope 3 Emissions and Their Significance for Zuellig Pharma

Scope 3 emissions are indirect greenhouse gas emissions that occur in a company's value chain, both upstream and downstream. These emissions are crucial for Zuellig Pharma because they represent a significant portion of the company's overall carbon footprint, particularly within the healthcare services industry where approximately 70% of greenhouse gas emissions are estimated to reside in the value chain. Managing these emissions is therefore central to the company's decarbonisation strategy.
Understanding Scope 3 Emissions

Scope 3 emissions encompass a broad range of indirect activities. This includes emissions generated from the extraction and production of purchased materials, the transportation and distribution of products, employee commuting, business travel, and the use of sold products by customers, as well as waste disposal. For companies like Zuellig Pharma, these emissions are generated throughout their extensive network of suppliers and the lifecycle of the healthcare products they distribute and service.
Zuellig Pharma's Focus on Scope 3

Zuellig Pharma directs a substantial part of its greenhouse gas reduction efforts towards Scope 3 emissions, primarily through its procurement policies. The company integrates sustainability criteria into its supplier selection and contracting processes, giving preference to suppliers who actively work to lower their carbon footprint. This strategic focus acknowledges that addressing emissions beyond direct operations is essential for achieving comprehensive climate action.
Strategic Supplier Engagement and Targets

To effectively manage Scope 3 emissions, Zuellig Pharma engages closely with its largest suppliers, mapping their environmental targets against the company's own carbon reduction goals. This collaborative approach involves requiring suppliers to report on the carbon impact of their activities. Furthermore, Zuellig Pharma has set a specific target to reduce absolute Scope 3 greenhouse gas emissions by 25% by the year 2030, underscoring the importance of this category in their sustainability agenda.

Reading history

Hide →

This history is cleared when the page is closed.

What are Scope 3 emissions and why are they crucial for Zuellig Pharma?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends